Randa Loutfi

2.1k total citations
10 papers, 272 citations indexed

About

Randa Loutfi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Randa Loutfi has authored 10 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Randa Loutfi's work include Breast Cancer Treatment Studies (3 papers), Global Cancer Incidence and Screening (2 papers) and HER2/EGFR in Cancer Research (2 papers). Randa Loutfi is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Global Cancer Incidence and Screening (2 papers) and HER2/EGFR in Cancer Research (2 papers). Randa Loutfi collaborates with scholars based in United States. Randa Loutfi's co-authors include Tessa Cigler, Alison Stopeck, Elizabeth Crowley, Ira A. Oliff, Linda T. Vahdat, Andres Forero, Agustin A. García, Denise A. Yardley, Scott Cruickshank and Dennis L. Citrin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgical Oncology.

In The Last Decade

Randa Loutfi

10 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randa Loutfi United States 7 162 67 58 42 38 10 272
Fabio Girardi Italy 8 187 1.2× 50 0.7× 46 0.8× 17 0.4× 46 1.2× 27 387
Marta Capelán United Kingdom 8 202 1.2× 81 1.2× 66 1.1× 11 0.3× 35 0.9× 20 321
Lucy Guerra United States 9 128 0.8× 19 0.3× 33 0.6× 40 1.0× 19 0.5× 24 243
Sarah Barrett Ireland 8 156 1.0× 58 0.9× 96 1.7× 9 0.2× 18 0.5× 25 282
K. Mohammed United Kingdom 11 153 0.9× 24 0.4× 70 1.2× 16 0.4× 36 0.9× 19 317
Christina Yeon United States 8 258 1.6× 60 0.9× 97 1.7× 15 0.4× 70 1.8× 26 367
S. Verma Canada 13 217 1.3× 50 0.7× 62 1.1× 13 0.3× 50 1.3× 20 450
Sasha Lupichuk Canada 10 157 1.0× 31 0.5× 64 1.1× 16 0.4× 79 2.1× 29 328
Giacomo Loseto Italy 11 158 1.0× 28 0.4× 33 0.6× 9 0.2× 26 0.7× 24 343
Vittorio Gebbia Italy 8 148 0.9× 38 0.6× 63 1.1× 19 0.5× 39 1.0× 46 241

Countries citing papers authored by Randa Loutfi

Since Specialization
Citations

This map shows the geographic impact of Randa Loutfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randa Loutfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randa Loutfi more than expected).

Fields of papers citing papers by Randa Loutfi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randa Loutfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randa Loutfi. The network helps show where Randa Loutfi may publish in the future.

Co-authorship network of co-authors of Randa Loutfi

This figure shows the co-authorship network connecting the top 25 collaborators of Randa Loutfi. A scholar is included among the top collaborators of Randa Loutfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randa Loutfi. Randa Loutfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Loutfi, Randa, et al.. (2022). Abiraterone acetate for treatment of ectopic Cushing syndrome caused by ACTH-producing neuroendocrine tumor: a case report. Journal of Gastrointestinal Oncology. 13(5). 2626–2632. 5 indexed citations
2.
Kerrigan, Dennis J., Eleanor Walker, Bernard Cook, et al.. (2022). Cardiac Rehabilitation Improves Fitness in Patients With Subclinical Markers of Cardiotoxicity While Receiving Chemotherapy. Journal of Cardiopulmonary Rehabilitation and Prevention. 43(2). 129–134. 19 indexed citations
3.
Loutfi, Randa, et al.. (2019). Four versus six cycles of docetaxel and cyclophosphamide in early breast cancer.. Journal of Clinical Oncology. 37(15_suppl). e12047–e12047. 2 indexed citations
4.
Ivanics, Tommy, Erica Proctor, Yalei Chen, et al.. (2019). Evaluation of a Multidisciplinary Team Approach for Generating Survivorship Care Plan Treatment Summaries in Patients With Breast Cancer. Journal of Oncology Practice. 15(5). e467–e474. 7 indexed citations
5.
Chen, Yalei, Laura Susick, Jessica Bensenhaver, et al.. (2019). Distribution and Short‐term Prognostic Value of the 21‐gene recurrence score in African American compared to White American breast cancer patients. The Breast Journal. 25(4). 667–671. 3 indexed citations
6.
7.
Eggly, Susan, Lauren M. Hamel, Tanina Foster, et al.. (2016). Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologists. Patient Education and Counseling. 100(5). 818–826. 60 indexed citations
8.
Yardley, Denise A., Robert Weaver, Michelle Melisko, et al.. (2015). EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer. Journal of Clinical Oncology. 33(14). 1609–1619. 145 indexed citations
9.
Yardley, DA, MN Saleh, Andres Forero, et al.. (2012). Abstract P6-10-01: A randomized phase 2 study of the antibody-drug conjugate CDX-011 in advanced GPNMB-overexpressing breast cancer: The EMERGE study. Cancer Research. 72(24_Supplement). P6–10. 12 indexed citations
10.
Torcuator, Roy, Richard Zuniga, Randa Loutfi, & Tom Mikkelsen. (2009). Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report. Journal of Neuro-Oncology. 93(3). 409–412. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026